HIV and TB Overview: Peru

At a glance

CDC works with partners in Peru to build sustainable public health capacity, strengthen laboratory systems and surveillance networks, deliver high-quality HIV diagnostic, treatment, and prevention services, and respond swiftly to disease outbreaks at their source, preventing health threats from reaching the U.S.

The flag of Peru has a red strip on the far right, a white strip in the middle, and a red strip on the far left.

Strategic focus

In partnership with governments, civil society, and other partners, CDC prioritizes interventions that directly impact the quality of services for people living with HIV (PLHIV) and people at greater risk for HIV, such as mobile populations. CDC supports the scale-up of evidence-based programs to bridge service delivery gaps in HIV prevention, case finding, early antiretroviral therapy (ART) initiation, optimized treatment services, and achieving viral load suppression through a targeted approach to strengthen systems essential for a sustainable HIV response.

Read more about CDC's most recent key activities and accomplishments below.

Resource

Download CDC's HIV and TB Peru fact sheet.
View

Building public health capacity

  • Provided expertise to Ministries of Health to update HIV service manuals, adapt communication materials and job aids to the South American context, train healthcare workers in HIV combination prevention and viral load monitoring, and support the integration of mobile PLHIV into national health services.

Strengthening laboratory systems and networks

  • Supported access to viral load testing among mobile PLHIV, as well as retention and re-engagement of those who are not in care or virally suppressed.

HIV prevention and treatment

  • Supported tailored HIV testing and prevention services for populations traveling through Peru, including people at greater risk for HIV. This package includes risk-based counseling, enhanced testing, and peer navigation for linkage to treatment.
  • Contributed to the introduction of pre-exposure prophylaxis (PrEP) for people at greater risk for HIV.
  • Strengthened a comprehensive treatment package for mobile populations, including rapid ART initiation, diagnosis, and management of HIV advanced disease and HIV-associated TB, intensified adherence counseling, and follow-up of HIV patients through case management teams.
  • Improved access to HIV testing among undiagnosed mobile PLHIV by supporting case-finding strategies, including testing as part of outreach strategies for people at greater risk for HIV, index testing services, social network testing, self-testing, and optimized provider-initiated testing.

By the numbers

HIV

Estimated HIV Prevalence (Ages 15-49)

0.5.% (2023)

Estimated HIV Deaths (Age ≥15)

<1,000 (2023)

Reported Number Receiving Antiretroviral Therapy (ART) (Age ≥15)

90,030 (2023)

TB

Estimated TB Incidence

173/100,000 population (2023)

Reported Percent of People with TB and HIV

6.0% (2023)

TB Treatment Success Rate

84% (2022)

Print
Content Source: